as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
1.00%
Downside
2.76%
Upside
52 Week's Low
52 Week's High
1.00%
Downside
90.24%
Upside
Check Haemonetics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.4B
EPS (TTM)
4.5443
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.05%
PE Ratio (TTM)
15.28
Industry PE ratio
10.127857142857144
P/B Ratio
15.2752
PEG Ratio
1.2149
EBITDA
369.6M
Revenue (TTM)
1.3B
Profit Margin
12.14%
Return On Equity TTM
18.27%
Track how Haemonetics Corp P/E has moved over time to understand its valuation trends.
Haemonetics Corp in the last 5 years
Lowest (15.76x)
June 30, 2025
Industry (10.13x)
September 18, 2025
Today (15.28x)
September 18, 2025
Highest (52.66x)
March 31, 2021
Today’s Price to Earnings Ratio: 15.28x
Compare market cap, revenue, PE, and other key metrics of Haemonetics Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.4B | -39.73% | 15.28 | 12.14% | |
BUY | $146.7B | 149.51% | 58.92 | 13.55% | |
BUY | $144.0B | 78.01% | 50.02 | 12.25% | |
BUY | $231.1B | 24.47% | 16.66 | 32.43% | |
BUY | $120.8B | -12.63% | 26.02 | 13.63% |
The Haemonetics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Haemonetics Corp investment value today
Current value as on today
₹70,635
Returns
Returns from Haemonetics Corp Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Haemonetics Corp. Average target price of $78.64
Get share price movements and forecasts by analysts on Haemonetics Corp.
What analysts predicted
36.51%UPSIDE
Target Price
$78.64
Current Price
$49.93
Analyzed by
11 Analysts
Target
$78.64
Haemonetics Corp target price $78.64, a slight upside of 36.51% compared to current price of $49.93. According to 11 analysts rating.
Search interest for Haemonetics Corp Stock has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Boston Scientific Corp. has given 136.2% return, outperforming this stock by 171.1%
Against Peers
In the last 1 year, Boston Scientific Corp. has given 19.3% return, outperforming this stock by 53.2%
Profit Down
Netprofit is down for the last 2 quarters, 57.98M → 34.03M (in $), with an average decrease of 41.3% per quarter
Revenue Fall
Revenue is down for the last 3 quarters, 348.54M → 321.39M (in $), with an average decrease of 4.0% per quarter
Price Dip
In the last 7 days, HAE stock has moved down by -6.6%
Organisation | Haemonetics Corp |
Headquarters | 125 Summer Street, Boston, MA, United States, 02110 |
Industry | Health Technology |
CEO | Mr. Christopher A. Simon |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Frank W. Chan Ph.D. | Executive VP & COO |
Mr. Rajeev Varma | Senior Vice President of Strategy & Corporate Development |
Mr. James C. D'Arecca CPA | CFO, Executive VP & Financial Officer |
Ms. Michelle L. Basil Esq., J.D. | Executive VP, General Counsel & Secretary |
Mr. Roy Galvin | Executive VP & Chief Commercial Officer |
Ms. Laurie A. Miller | Senior VP & Chief Human Resources Officer |
Dr. Jan Hartmann M.D. | Senior VP & Chief Medical Officer |
Mr. Christopher A. Simon | CEO, President & Director |
Ms. Farris Maryanne Maunsell | VP, Chief Accounting Officer & Principal Accounting Officer |
Ms. Olga Guyette | Senior Director of Investor Relations |
Haemonetics Corp share price today is $49.93 as on at the close of the market. Haemonetics Corp share today touched a day high of $51.31 and a low of $49.43.
Haemonetics Corp share touched a 52 week high of $94.99 on and a 52 week low of $49.43 on . Haemonetics Corp stock price today i.e. is closed at $49.93,which is 47.43% down from its 52 week high and 1.01% up from its 52 week low.
Haemonetics Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Haemonetics Corp (HAE) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Haemonetics Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Haemonetics Corp share’s latest price of $49.93 as on September 18, 2025 at 1:29 am IST, you will get 0.2003 shares of Haemonetics Corp. Learn more about
fractional shares .
Haemonetics Corp stock has given -39.73% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?